FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

9552011000001100: Agalsidase alfa (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 22-Aug 2012. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    31102701000001113 Agalsidase alfa (substance) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    31102801000001116 Agalsidase alfa en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Agalsidase alfa Is a Beta-galactosidase false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Agalsidase alfa 1mg/1ml solution for injection vials Has active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Replagal 1mg/1ml solution for injection vials (Shire Pharmaceuticals Ltd) Has active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Replagal 3.5mg/3.5ml solution for infusion vials (Takeda UK Ltd) Has active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Replagal 1mg/1ml solution for injection vials (Shire Pharmaceuticals Ltd) Has specific active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Replagal 1mg/1ml solution for injection vials (Shire Pharmaceuticals Ltd) 1 vial Has specific active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Agalsidase alfa 1mg/1ml solution for injection vials 1 vial Has specific active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Agalsidase alfa 1mg/1ml solution for injection vials Has specific active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Agalsidase alfa 3.5mg/3.5ml solution for injection vials 10 vial Has specific active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Replagal 3.5mg/3.5ml solution for infusion vials (Takeda UK Ltd) 1 vial Has specific active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has specific active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Replagal 3.5mg/3.5ml solution for infusion vials (Takeda UK Ltd) Has specific active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial Has specific active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Replagal 3.5mg/3.5ml solution for infusion vials (Takeda UK Ltd) 4 vial Has specific active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Replagal 3.5mg/3.5ml solution for infusion vials (Takeda UK Ltd) 10 vial Has specific active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
    Agalsidase alfa 3.5mg/3.5ml solution for injection vials 1 vial Has specific active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start